Results 71 to 80 of about 74,283 (261)
BMC Public HealthBackground Men’s involvement in and support for women’s decision-making concerning human papillomavirus (HPV) vaccination is crucial. However, the support provided by men to promote HPV vaccination among women, as a crucial part of intimate relationships
Weiyi Wang
doaj +1 more source
Current Oncology, 2016 The human papilloma virus (HPV) was at one time deemed benign, with few variants [...]
openaire +2 more sources
Extended HPV typing as an efficient alternative within HPV‐based screening programs
International Journal of Cancer, EarlyView.What's New? Extended high‐risk human papillomavirus (hrHPV) typing holds promise for improving cervical intraepithelial neoplasia grade 3 (CIN3) detection, particularly as vaccinated cohorts may shift the prevalence of oncogenic HPV types. The authors of this study evaluated extended hrHPV genotyping within a public screening program involving women ...
Joacim Meneses‐León +11 more
wiley +1 more source
Why not boys? The human papillomavirus vaccine schedule in the UK [PDF]
, 2016 The aim of this paper is to explore the ethical issues on why boys are not currently included in the human papillomavirus vaccination schedule in the United Kingdom (UK).
Kelly, Janet Clair, Millington, Helen
core +1 more source
Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States
Human Vaccines & Immunotherapeutics, 2019 HPV vaccination coverage in the United States (US) falls short of the Healthy People 2020 goal of 80% coverage among 13–15 year-old adolescents. Pharmacies are a promising alternative vaccine delivery site that may increase access to HPV vaccination. Our
Jessica Y. Islam +7 more
doaj +1 more source
International Journal of Cancer, EarlyView.What's New? Cancers of the breast and female genital tract represent more than half of all cancers in women in sub‐Saharan Africa. Here, the authors assessed incidence trends in a female population living in urban sub‐Saharan Africa based on the Zimbabwe National Cancer Registry in Harare over a 30‐year period.
Eric Chokunonga +7 more
wiley +1 more source
Human Papillomavirus (HPV) Vaccine: Attitudes, Behaviors, and Beliefs of At-Risk Women [PDF]
, 2008 Cervical cancer is primarily caused by human papillomavirus (HPV) and is the second most common cause of cancer-related mortality among women. Female college students may be at risk for contracting HPV based on their sexual behavior.
Caron, Rosemary M +2 more
core +1 more source
Mandatory HPV Vaccination and Political Debate [PDF]
, 2011 Vaccinations are among the most cost-effective and widely used public health interventions, but have provoked popular resistance, with compulsion framed as an unwarranted state interference.
Gostin, Lawrence O.
core +2 more sources
HPV vaccines: Global perspectives [PDF]
Human Vaccines & Immunotherapeutics, 2017 The discovery of HPV as the etiological factor for HPV-associated malignancies and disease has opened up several opportunities for prevention and therapy. Current commercially available HPV vaccines (Gardasil, Gardasil 9, and Cervarix) are prophylactic in nature and derived from adjuvanted L1-based virus-like particles of HPV. Globally, through several
Gaurav Gupta +2 more
openaire +3 more sources
International Journal of Cancer, EarlyView.What's New? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas +13 more
wiley +1 more source